2 Late-Stage Coronavirus Vaccine Candidates in Limbo

Keith Speights, The Motley Fool
·3 min read

U.S. phase 3 studies for AstraZeneca's and Johnson & Johnson's coronavirus vaccines still haven't resumed. Should investors be worried?